GB1125409A - Pharmaceutical compositions containing sulphoxides - Google Patents

Pharmaceutical compositions containing sulphoxides

Info

Publication number
GB1125409A
GB1125409A GB3380266A GB3380266A GB1125409A GB 1125409 A GB1125409 A GB 1125409A GB 3380266 A GB3380266 A GB 3380266A GB 3380266 A GB3380266 A GB 3380266A GB 1125409 A GB1125409 A GB 1125409A
Authority
GB
United Kingdom
Prior art keywords
sulphoxides
compositions
penetrant
aliphatic
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3380266A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1125409A publication Critical patent/GB1125409A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB3380266A 1965-08-02 1966-07-27 Pharmaceutical compositions containing sulphoxides Expired GB1125409A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47667665A 1965-08-02 1965-08-02

Publications (1)

Publication Number Publication Date
GB1125409A true GB1125409A (en) 1968-08-28

Family

ID=23892803

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3380266A Expired GB1125409A (en) 1965-08-02 1966-07-27 Pharmaceutical compositions containing sulphoxides

Country Status (5)

Country Link
BE (1) BE684960A (cg-RX-API-DMAC7.html)
FR (2) FR5698M (cg-RX-API-DMAC7.html)
GB (1) GB1125409A (cg-RX-API-DMAC7.html)
IL (1) IL26210A (cg-RX-API-DMAC7.html)
NL (1) NL6610878A (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888164A (en) * 1985-12-27 1989-12-19 L'oreal Cosmetic composition for the treatment of oily skin and hair based on di(beta-hydroxyethyl) sulfoxide and the use thereof
EP1693052A1 (en) * 2001-10-03 2006-08-23 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US9271931B2 (en) 2001-10-03 2016-03-01 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US10058507B2 (en) 2001-10-03 2018-08-28 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984480A (en) * 1970-05-12 1976-10-05 L'oreal Polyhydroxyl monosulfoxide surfactant

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888164A (en) * 1985-12-27 1989-12-19 L'oreal Cosmetic composition for the treatment of oily skin and hair based on di(beta-hydroxyethyl) sulfoxide and the use thereof
EP1693052A1 (en) * 2001-10-03 2006-08-23 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US9271931B2 (en) 2001-10-03 2016-03-01 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US10058507B2 (en) 2001-10-03 2018-08-28 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US10722464B2 (en) 2001-10-03 2020-07-28 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations

Also Published As

Publication number Publication date
BE684960A (cg-RX-API-DMAC7.html) 1967-02-02
FR1505490A (fr) 1967-12-15
NL6610878A (cg-RX-API-DMAC7.html) 1967-02-03
FR5698M (cg-RX-API-DMAC7.html) 1968-02-19
IL26210A (en) 1970-12-24

Similar Documents

Publication Publication Date Title
Fox Silver sulfadiazine—a new topical therapy for pseudomonas in burns: therapy of pseudomonas infection in burns
US4536404A (en) Method and composition for treating post-herpetic neuralgia
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
ES8702784A1 (es) Un procedimiento para preparar una composicion anticaspa a base de una sal de 1-hidroxi-2-piridintiona y una hidroxipiridona.
NO932785D0 (no) Preparat
DE69308969D1 (de) Titansalz enthaltende, schweisshemmende Mittel und Zusammensetzung
NO20061917L (no) Belagt metal pyrition partikler for behandling av mikroorganismer
KR900013969A (ko) 지루를 감소시키는 약학 조성물의 제조에 있어서 5'-데옥시-5'-메틸티오아데노신, s-아데노실메티오닌 및 이들의 염의 용도 및 이와 관련된 약학 조성물
GB1125410A (en) Pharmaceutical compositions containing sulphones
AU530678B2 (en) Phosphono-hydroxy-acetic acid
IT7829910A0 (it) Derivati dell'acido fosfonoso, procedimenti per la loro preparazione e loro impiego per combattere microorganismi.
NO822681L (no) Vannfortynnbart preparat med baktericid og fungicid virkning
KR920700627A (ko) 치료제로서 1-페닐-2-아미노에탄올 유도체의 신규한 용도
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
BE899634A (fr) Composition cosmetique pour le traitement des cheveux et de la peau, contenant des oxathiazinones.
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
ATE24716T1 (de) Lenkotrien-antagonisten.
BE900186A (fr) Compositions fongicides synergiques.
EP0377413B1 (en) Pharmaceutical compositions having topical use comprising ticlopidine
ZA855761B (en) Use of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing them
KR950703528A (ko) 프로스타글란딘 e₁유연체
EP0537177B1 (en) Nitrogen and silver containing derivative
JPS6468304A (en) Antiseptic agent